Serial Number | 98139183 |
Word Mark | EVERSANA ONCOLOGY COMMERCIALIZATION |
Filing Date | Friday, August 18, 2023 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, July 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Oncology and hematology new product commercialization service for drug companies, namely, providing access to launch strategy, marketing strategy, commercialization modeling for advertising or sales promotion, and market access services in the nature of pricing and reimbursement support, guideline and formulary submission support, pathway submission support, and advocacy planning |
NOT AVAILABLE | "ONCOLOGY COMMERCIALIZATION" |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 18, 2023 |
Primary Code | 035 |
First Use Anywhere Date | Monday, June 7, 2021 |
First Use In Commerce Date | Monday, June 7, 2021 |
Party Name | Eversana Life Science Services, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Milwaukee, WI 53202 |
Event Date | Event Description |
Tuesday, August 22, 2023 | NEW APPLICATION ENTERED |
Monday, September 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, April 9, 2024 | ASSIGNED TO EXAMINER |
Monday, July 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, July 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, July 9, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, July 9, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, July 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, April 16, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 16, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, April 16, 2024 | NON-FINAL ACTION E-MAILED |